Naruhodo #364 - O que é e quais são os impactos do Pós-COVID? - Parte 1 de 2

Há pessoas que, mesmo depois de "negativadas" após se infectar com o coronavírus, continuam tendo um ou mais sintomas da doença. O que a ciência tem a dizer sobre a pós-COVID ou COVID longa? Por que isso importa? Confira a parte 1 deste episódio duplo, no papo entre o leigo curioso, Ken Fujioka, e o cientista PhD, Altay de Souza. > OUÇA (52min 08s) * Naruhodo! é o podcast pra quem tem fome de aprender. Ciência, senso comum, curiosidades, desafios e muito mais. Com o leigo curioso, Ken Fujioka, e o cientista PhD, Altay de Souza. Edição: Reginaldo Cursino. http://naruhodo.b9.com.br * PARCERIA: ALURA Aprofunde-se de vez: garantimos conhecimento com profundidade e diversidade, para se tornar um profissional em T - incluindo programação, front-end, data science, devops, ux & design, mobile, inovação & gestão. Navegue sua carreira: são mais de 1300 cursos e novos lançamentos toda semana, além de atualizações e melhorias constantes. Conteúdo imersivo: faça parte de uma comunidade de apaixonados por tudo que é digital. Mergulhe na comunidade Alura. Aproveite o desconto para ouvintes Naruhodo no link: https://bit.ly/naruhodo_alura * REFERÊNCIAS Diário de um Extubado - Episódios https://podcasts.apple.com/us/podcast/diário-de-um-extubado/id1528224825 A multinational Delphi consensus to end the COVID-19 public health threat https://www.nature.com/articles/s41586-022-05398-2 Acute and postacute sequelae associated with SARS-CoV-2 reinfection https://www.nature.com/articles/s41591-022-02051-3#MOESM1 Long COVID or Post-COVID Conditions https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html Vaccine hesitancy in the era of COVID-19 https://www.sciencedirect.com/science/article/pii/S0033350621000834?casa_token=yFG73GWZPtcAAAAA:zbTt9INuQaw9TEDv7gmYkruwwXhIjCLoW8BAO0ZhwUjV5WaC9sRiT7SjTdSKxNsTT3_pf6oPF7A Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis https://www.mdpi.com/2076-393X/10/8/1356 Partisanship and the Politics of COVID Vaccine Hesitancy https://www.journals.uchicago.edu/doi/abs/10.1086/719918 Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future? https://www.tandfonline.com/doi/full/10.1080/21645515.2021.1893062 How and why patients made Long Covid https://www.sciencedirect.com/science/article/pii/S0277953620306456 Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00385-4/fulltext More than 50 long-term effects of COVID-19: a systematic review and meta-analysis https://www.nature.com/articles/s41598-021-95565-8 One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms https://www.mdpi.com/2077-0383/10/15/3305 Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021204/ Post-Ebola Syndrome among Ebola Virus Disease Survivors in Montserrado County, Liberia 2016 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046154/ Mast cell activation symptoms are prevalent in Long-COVID https://www.sciencedirect.com/science/article/pii/S1201971221007517 Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection https://www.sciencedirect.com/science/article/pii/S155541552100547X Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine https://www.sciencedirect.com/science/article/pii/S0264410X15014334 Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study https://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-11-37 Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? https://www.frontiersin.org/articles/10.3389/fmed.2020.606824/full Chronic fatigue syndrome and long covid: moving beyond the controversy https://www.bmj.com/content/373/bmj.n1559.short Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies https://onlinelibrary.wiley.com/doi/full/10.1002/rmv.2315 Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus https://academic.oup.com/eurheartj/article/43/11/1157/6529562 Cardiac function in relation to functional status and fatigue in patients with post-COVID syndrome https://www.nature.com/articles/s41598-022-24038-3 Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications https://www.sciencedirect.com/science/article/pii/S1521694222000535?casa_token=NomtNqGMCbYAAAAA:5c1zCxPY72P3Hnz2-UI-TNZ-zPJjYd95_5M11CExdsHnLLfJrREAfSZVHxY2yoVTiYdxrDjMWKg Naruhodo #314 - COVID 2021: de onde viemos e para onde vamos? - Parte 1 de 2 https://www.youtube.com/watch?v=oLDbaKxnMHI Naruhodo #315 - COVID 2021: de onde viemos e para onde vamos? - Parte

Naruhodo · Altay de Souza, Naruhodo, Ken Fujioka, B9